Chapter 1. Promise and progress of central G-protein coupled receptor modulators for obesity treatments

This publication has 72 references indexed in Scilit:

• The Neuropeptide Y (NPY) Y1 Receptor Subtype Mediates NPY-induced Antidepressant-like Activity in the Mouse Forced Swimming Test
  Neuropsychopharmacology, 2002
• Hypothalamic peptides as drug targets for obesity
  Current Opinion in Pharmacology, 2001
• Potent and Selective Peptide Agonists of α-Melanotropin Action at Human Melanocortin Receptor 4: Their Synthesis and Biological Evaluation in Vitro
  Biochemical and Biophysical Research Communications, 2001
• Structure Activity Studies of the Melanocortin-4 Receptor by in Vitro Mutagenesis: Identification of Agouti-Related Protein (AGRP), Melanocortin Agonist and Synthetic Peptide Antagonist Interaction Determinants
  Biochemistry, 2001
• Highly Selective and Potent Neuropeptide Y (NPY) Y1 Receptor Antagonists Based on [Pro³⁰, Tyr³², Leu³⁴]NPY(28-36)-NH₂ (BW1911U90)
  Journal of Medicinal Chemistry, 2001
• Melanocortin receptors: new opportunities in drug discovery
  Expert Opinion on Therapeutic Patents, 2001
• Expression of a Novel Neuropeptide Y Receptor Subtype Involved in Food Intake: An in Situ Hybridization Study of Y5 mRNA Distribution in Rat Brain
  Experimental Neurology, 2000
• Novel anti-obesity drugs
  Expert Opinion on Investigational Drugs, 2000
• NPY Y1 receptor like immunoreactivity exists in a subpopulation of β-endorphin immunoreactive nerve cells in the arcuate nucleus: a double immunolabelling analysis in the rat
  Neuroscience Letters, 1997
• Characterization of a human gene related to genes encoding somatostatin receptors
  FEBS Letters, 1996